Arax Advisory Partners’s Vivani Medical VANI Stock Holding History

Arax Advisory Partners’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$124K	Buy	+100,000	New	+$134K	﹤0.01%	2664

Other funds holding VANI

Tanager Wealth Management Goring On Thames, United Kingdom $1.2B AUM 12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return

Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Arax Advisory Partners's VANI Position: Q3 2026 in Review

Arax Advisory Partners opened a new position in Vivani Medical (VANI) in Q3 2026: 100,000 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2664 among its holdings.

20 funds tracked by Wall St. Rank hold VANI as of Q3 2026.

Arax Advisory Partners held 100,000 shares of Vivani Medical worth $124K as of Q3 2026.
Vivani Medical was a new Arax Advisory Partners position in Q3 2026.
Vivani Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2664 holding.
20 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.